Chugai Pharma (United States)

1.3k papers and 32.8k indexed citations

About

In recent decades, authors affiliated with Chugai Pharma (United States) have published 1.3k papers, which have received a total of 32.8k indexed citations. Scholars at this organization have produced 462 papers in Molecular Biology, 266 papers in Oncology and 175 papers in Immunology on the topics of Monoclonal and Polyclonal Antibodies Research (111 papers), Glycosylation and Glycoproteins Research (57 papers) and Protein purification and stability (48 papers). Their work is cited by papers focused on Molecular Biology (11.9k citations), Oncology (7.0k citations) and Immunology (4.4k citations). Authors at Chugai Pharma (United States) collaborate with scholars in United States, Japan and United Kingdom and have published in prestigious journals including Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences. Some of Chugai Pharma (United States)'s most productive authors include Masahiko Mihara, Yoshiyuki Ohsugi, Misato Hashizume, Kunio Ando, Kunio Kitada, Hideaki Mizuno, Akinori Sarai, Kenta Nakai, Kazushige Sakai and Kunihiro Hattori.

In The Last Decade

Chugai Pharma (United States)

1.3k papers receiving 32.5k citations

Fields of papers published by authors at Chugai Pharma (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Chugai Pharma (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Chugai Pharma (United States) at the time of their publication.

Countries citing scholars working at Chugai Pharma (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Chugai Pharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Chugai Pharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chugai Pharma (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026